Transplant center directory

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Blood and Marrow Transplant Program, an NCI-designated Cancer Center, has been serving the Baltimore metropolitan area, Maryland and the mid-Atlantic states since 1993. We specialize in matched sibling, matched unrelated and haploidentical family member donor transplants for all types of hematologic malignancies and bone marrow failure syndromes in both adults and children. We also offer advanced research studies in the areas of immunotherapy, infection prevention and supportive care. We are also closely aligned with outstanding clinical programs in leukemia, lymphoma and myeloma to ensure cohesive and comprehensive care. In addition, we have a large cellular therapy program.

This center has been performing allogeneic transplants since 1995 and has been an NMDP/Be The Match transplant center since November 1997.

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
2. Who had their transplant at a U.S. transplant center, and
3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 109 patients.

The actual 1-year survival of these patients is 76.9%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 68.0% and 83.6%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

All diseases

Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.